"Syntenins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Intracellular signaling adaptor proteins that play a role in the coupling of SYNDECANS to CYTOSKELETAL PROTEINS.
| Descriptor ID |
D053676
|
| MeSH Number(s) |
D12.644.360.024.437 D12.776.157.057.374 D12.776.476.024.468
|
| Concept/Terms |
Syntenins- Syntenins
- Syndecan Binding Proteins
- Syntenin
Syntenin-1- Syntenin-1
- Syntenin 1
- Melanoma Differentiation-Associated Protein 9
- Melanoma Differentiation Associated Protein 9
- Scaffold Protein Pbp1
- Syndecan Binding Protein 1
Syntenin-2- Syntenin-2
- Syntenin 2
- Syndecan Binding Protein-2
- Syndecan Binding Protein 2
|
Below are MeSH descriptors whose meaning is more general than "Syntenins".
Below are MeSH descriptors whose meaning is more specific than "Syntenins".
This graph shows the total number of publications written about "Syntenins" by people in this website by year, and whether "Syntenins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 2 | 0 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Syntenins" by people in Profiles.
-
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis. Proc Natl Acad Sci U S A. 2023 Nov 07; 120(45):e2307094120.
-
Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Mol Cancer Ther. 2023 Oct 02; 22(10):1115-1127.
-
Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1?. Proc Natl Acad Sci U S A. 2021 05 25; 118(21).
-
MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein. Cancer Metastasis Rev. 2020 09; 39(3):769-781.
-
MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis. Pharmacol Res. 2020 05; 155:104695.
-
Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin. Oncogene. 2019 10; 38(41):6781-6793.
-
Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor. Mol Cancer Ther. 2019 11; 18(11):1997-2007.
-
Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin. Autophagy. 2018; 14(10):1845-1846.
-
MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells. Proc Natl Acad Sci U S A. 2018 05 29; 115(22):5768-5773.
-
The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. Cancer Res. 2018 06 01; 78(11):2852-2863.